CDNS

Cadence Design Systems Inc
NASDAQTECHNOLOGYSOFTWARE - APPLICATION

Key Statistics

Market Cap
$89.22B
P/E Ratio
64.56
EPS
$5.01
Beta
1.14
52W High
$416.69
52W Low
$262.75
50-Day MA
$361.26
200-Day MA
$327.60
Dividend Yield
Profit Margin
23.60%
Forward P/E
40.16
PEG Ratio
2.94

About Cadence Design Systems Inc

Cadence Design Systems, Inc., headquartered in San Jose, California, is an American multinational computational software company. The company produces software, hardware and silicon structures for designing integrated circuits, systems on chips (SoCs) and printed circuit boards.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.84B
Gross Profit (TTM)$5.01B
EBITDA$2.16B
Operating Margin28.60%
Return on Equity23.20%
Return on Assets10.60%
Revenue/Share (TTM)$21.46
Book Value$24.90
Price-to-Book13.04
Price-to-Sales (TTM)15.26
EV/Revenue15.53
EV/EBITDA39.82
Quarterly Earnings Growth (YoY)125.40%
Quarterly Revenue Growth (YoY)24.20%
Shares Outstanding$275.82M
Float$274.15M
% Insiders0.33%
% Institutions91.90%

Historical Volatility

HV 10-Day
16.95%
HV 20-Day
31.85%
HV 30-Day
40.50%
HV 60-Day
44.68%
HV Rank
53.2%

Volatility is currently contracting

Analyst Ratings

Consensus ($403.67 target)
5
Strong Buy
17
Buy
3
Hold

Latest News

INTU or CDNS: Which Is the Better Value Stock Right Now?

Investors interested in Computer - Software stocks are likely familiar with Intuit (INTU) and Cadence Design Systems (CDNS). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research8/18/2026Positive
Cadence's HypertensionOS Software Announced as Second Participant in FDA's TEMPO to Advance Hypertension Care

NEW YORK--(BUSINESS WIRE)--Cadence, the clinical AI company automating the treatment of chronic disease, today announced its HypertensionOS software has been selected by the U.S. Food and Drug Administration as the second participant in the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. HypertensionOS is prescription software as a medical device (“SaMD”) that incorporates AI-assisted functionality to support clinician-supervised medication management fo.

Business Wire8/13/2026Neutral
Semiconductor Outlook Bodes Well for This ETF

Of late, some air has come out of the semiconductor bubble, but that's been to the benefit of the Direxion Daily Semiconductor Bear 3X Shares (SOXS). Entering July 27, the leveraged bearish ETF boasted a one-month gain of nearly 58%.

ETF Trends8/3/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CDNS and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More TECHNOLOGY Stocks

Data last updated: 8/18/2026